Vienna Ludovini
1, G. Dottori Street
Perugia, 06132, Italy
Perugia, 06132, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance.
Journal: Therapeutic advances in medical oncology
Published: April 02, 2025
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab.
Journal: Clinical and experimental medicine
Published: April 12, 2024
Corrigendum: A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: a case report.
Journal: Frontiers in oncology
Published: October 03, 2023
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases.
Journal: Journal of chemotherapy (Florence, Italy)
Published: December 20, 2022
A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report.
Journal: Frontiers in oncology
Published: November 18, 2022
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: August 26, 2022
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 24, 2022
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations.
Journal: Translational oncology
Published: February 18, 2022
Inflamed Tumor Phenotype as Predictor of Long-Term Response to Pembrolizumab in an EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patient with Acquired Resistance to Afatinib: a Case Report and Review of the Literature.
Journal: Oncology and therapy
Published: December 01, 2021
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine.
Journal: Journal for immunotherapy of cancer
Published: September 20, 2021
Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas.
Journal: Genes
Published: August 04, 2021
Last Updated: 09/26/2026